SCHEMBL166351

SCHEMBL166351

Oc1cc(Cl)cc2[nH]nnc12

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 3/20 0.35
HPGD P15428 1/20 0.35
IDO1 P14902 1/20 0.32
HTT P42858 1/20 0.32
DAO P14920 2/20 0.31
CYP3A4 P08684 2/20 0.31
TDP1 Q9NUW8 1/20 0.31
GRIN1 Q05586 2/20 0.30
GRIN2D O15399 1/20 0.30
GRIN3B O60391 1/20 0.30
GRIN2A Q12879 1/20 0.30
GRIN2B Q13224 1/20 0.30
GRIN2C Q14957 1/20 0.30
GRIN3A Q8TCU5 1/20 0.30
PIM1 P11309 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL2477029 0.98 ALDH1A1 (0.34) ALDH1A1TSHRHSD17B10HPGDIDO1
SCHEMBL6051981 0.79 ESR1 (0.34)
SCHEMBL1156230 0.79 HTT (0.46) ALDH1A1TSHRHSD17B10HPGDHTT
SCHEMBL9172800 0.78 ESR1 (0.33)
SCHEMBL6267453 0.76 HPGD (0.37) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL14468054 0.76 HTT (0.39) ALDH1A1HTTGRIN1GRIN2DGRIN3B
SCHEMBL22965656 0.76 AMY1A (0.36) HTT
SCHEMBL8624057 0.76 SELL (0.39) ALDH1A1IDO1DAORECQL
SCHEMBL3443090 0.73 CA12 (0.47) ALDH1A1TSHRHSD17B10HPGDCYP3A4
SCHEMBL4609294 0.72 RHEB (0.33) HTTGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3478669-A1 PROCESS OF PREPARING A PEPTIDE EPOXYKETONE IMMUNOPROTEASOME INHIBITOR, AND PRECURSORS THEREOF Kezar Life Sciences (US) 2019-05-08 EP claimed
WO-2018005781-A1 PROCESS OF PREPARING A PEPTIDE EPOXYKETONE IMMUNOPROTEASOME INHIBITOR, AND PRECURSORS THEREOF KEZAR LIFE SCIENCES (US) 2018-01-04 WO claimed
EP-2655527-A1 PROCESS FOR CURING SURFACE-COATING COMPOSITIONS ALLNEX AUSTRIA GmbH (AT) 2013-10-30 EP claimed
WO-2012085016-A1 PROCESS FOR CURING SURFACE-COATING COMPOSITIONS CYTEC AUSTRIA GMBH (AT) 2012-06-28 WO claimed
EP-2181118-A1 PROCESS FOR THE PRODUCTION OF PRAMLINTIDE LONZA AG (CH) 2010-05-05 EP claimed
WO-2009003666-A1 PROCESS FOR THE PRODUCTION OF PRAMLINTIDE LONZA AG (CH) 2009-01-08 WO claimed
EP-1917272-A1 NOVEL COUPLING AGENT AND USES THEREOF Luxembourg Industries Ltd. (IL) 2008-05-07 EP claimed
WO-2007020620-A1 NOVEL COUPLING AGENT AND USES THEREOF LUXEMBOURG INDUSTRIES LTD. (IL) 2007-02-22 WO claimed
CN-1798757-A Process for the preparation of steroidal carbothioic acid derivatives and intermediates ALPHARMA APS (DK) 2006-07-05 CN claimed
EP-1611149-A1 PROCESS FOR THE PREPARATION OF STEROIDAL CARBOTHIOIC ACID DERIVATIVES AND INTERMEDIATES Alpharma APS (DK) 2006-01-04 EP claimed
WO-2004087731-A1 PROCESS FOR THE PREPARATION OF STEROIDAL CARBOTHIOIC ACID DERIVATIVES AND INTERMEDIATES ALPHARMA APS (DK) 2004-10-14 WO claimed
EP-4255469-A1 ACYLATED SINGLE-CHAIN INSULIN ANALOGUES CASE WESTERN RESERVE UNIVERSITY (US) 2023-10-11 EP disclosed
WO-2023154907-A1 USES AND FORMULATIONS OF CAMPTOTHECIN (CPT)-CONTAINING NANOPARTICLES Dantari, Inc. (US) 2023-08-17 WO disclosed
EP-4161481-A1 ANTIBACTERIAL SYNTHETIC-BIOINFORMATIC NATURAL PRODUCTS AND USES THEREOF The Rockefeller University (US) 2023-04-12 EP disclosed
EP-4132960-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE SIDE CHAIN Fresenius Kabi Oncology Limited (IN) 2023-02-15 EP disclosed
EP-0125756-A2 Fused imidazole compounds, processes for the preparation thereof and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-11-21 EP disclosed
EP-0124889-A2 Process for the preparation of cephalosporins HOECHST AKTIENGESELLSCHAFT (DE) 1984-11-14 EP disclosed
EP-0098615-A1 1-Oxadethiacephalosporin compound and antibacterial agent containing the same MEIJI SEIKA KAISHA LTD. (JP) 1984-01-18 EP disclosed
EP-0035689-A1 4-Substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-09-16 EP disclosed
EP-0030630-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-24 EP disclosed